Biobank and Pathology Facility: A Successful Combination.
Biobank
financial sustainability
histology
Journal
Journal of biomolecular techniques : JBT
ISSN: 1943-4731
Titre abrégé: J Biomol Tech
Pays: United States
ID NLM: 100888641
Informations de publication
Date de publication:
15 04 2022
15 04 2022
Historique:
entrez:
15
7
2022
pubmed:
16
7
2022
medline:
19
7
2022
Statut:
epublish
Résumé
Financial sustainability in biobanks has recently become a key issue globally, as biorepositories struggle to balance limited external funding and high operating costs. To maximize governance and operational efficiency, the Pathology Facility and the University College London (UCL)/UCL Hospitals Biobank for Studying Health and Disease ("the Biobank") have been grouped together under the same management at the UCL Cancer Institute. This paper explores the operational and financial interaction between the Pathology Facility and the Biobank over a period of 3 years (2017-2019). Since 2017, only a minority of the requests included collection of samples from the archive or molecular biology services, and most of the requests included histology services. Our data confirmed the difficulty for a biobank to achieve financial sustainability. The integration of the Pathology Facility with the Biobank within a single laboratory management and delivery infrastructure was shown to be an effective management option and presented a unique opportunity to overcome financial and operational challenges, thus improving efficiency and lowering costs for both parties.
Identifiants
pubmed: 35837002
doi: 10.7171/3fc1f5fe.a423c94f
pmc: PMC9258917
pii:
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Cancer Research UK
Pays : United Kingdom
Informations de copyright
Copyright ©️ 2021 Association of Biomolecular Resource Facilities. All rights reserved.
Déclaration de conflit d'intérêts
Conflict of Interest Disclosures: The authors declare no conflicts of interest.
Références
Biopreserv Biobank. 2017 Feb;15(1):46-56
pubmed: 27898226
Sci Transl Med. 2011 Aug 10;3(95):95cm21
pubmed: 21832235
Biopreserv Biobank. 2013 Oct;11(5):309-15
pubmed: 24835262
J Biomol Tech. 2018 Sep;29(3):79-92
pubmed: 30140172
EMBO Rep. 2016 Aug;17(8):1088-93
pubmed: 27412771
J Transl Med. 2020 Jan 6;18(1):6
pubmed: 31907070
Biopreserv Biobank. 2019 Apr;17(2):129-138
pubmed: 30638412
Biopreserv Biobank. 2015 Dec;13(6):385-6
pubmed: 26697906
BMC Med Ethics. 2016 Jul 12;17(1):39
pubmed: 27405974
J Biomol Tech. 2013 Jul;24(2):87-97
pubmed: 23814500